Electronic health record providers are starting work that could transform how nursing homes grapple with prior authorization requests and length of stay determinations.
Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular ...
News-Medical.Net on MSN
New trial shows major survival gains with epcoritamab added to standard R2 therapy
In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results